top of page


Elisa Scarselli

Nouscom, Rome

Elisa Scarselli is currently CSO of Nouscom, a biotech dedicated to the development of novel vaccination strategies for cancer immunotherapy. She has wide experience in R&D from Pharma to Biotech mainly in the field of immunology and molecular biology and extensive expertise in Vaccine programs, from validation of genetic vaccine platform in pre-clinical models to design of clinical trials. She has published 68 papers on a range of subjects, including virology, immunology, and oncology.

bottom of page